Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
5Y CAGR+42.1%
Studio
Year-over-Year Change

Income taxes paid or accrued

5Y CAGR
+42.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$29.86M+324.1%
2024$7.04M+122.9%
2023$-30.74M+82.2%
2022$-172.34M-12543.1%
2021$1.39M-73.1%
2020$5.15M+351.7%
2019$-2.05M-856.5%
2018$-214000.00-10800.0%
2017$2000.00-94.4%
2016$36000.00-